Fast Facts
- Editor-in-Chief: Victor Aboyans (FR)
- Current volume: 32 (year 2025)
- Issues per subscription: 18
- Impact Factor 2023: 8.6
- The European Journal of Preventive Cardiology was formerly named the Journal of Cardiovascular Risk (June 1994 – August 2003) and the European Journal of Cardiovascular Prevention and Rehabilitation (August 2003 – December 2011)
Advertising, Reprints and Supplements
Oxford University Press (OUP), publisher of this and other ESC journals, offers a number of services which help you reach ESC audiences or re-use the content published by the journals for educational purposes:
• Print and digital advertising puts your marketing message in front of ESC journal readers
• A peer-reviewed supplement communicates scientific research via a themed collection of papers
• Reprints and ePrints are an ideal format for dissemination of published papers
• Licensing ESC content for excerpted local editions or CME ensures the best possible content for your region
Please contact OUP at jnlsadvertising@oup.com for further information.
Editor-in-Chief History
| Name | Profs. Hugo Saner & David A Wood |
| Start Date | 01/01/2003 |
| End date | 31/12/2005 |
| Name | Profs. Pantaleao Giannuzzi & David A Wood |
| Start Date | 01/01/2006 |
| End date | 31/12/2007 |
| Name | Profs. Pantaleao Giannuzzi & Diederick Grobbee |
| Start Date | 01/01/2008 |
| End date | 31/12/2009 |
| Name | Prof. Diederick Grobbee |
| Start Date | 01/01/2010 |
| End date | 31/12/2016 |
| Name | Prof. Massimo Piepoli |
| Start Date | 01/01/2017 |
| End date | 31/03/2024 |
| Name | Prof. Victor Aboyans |
| Start Date | 01/04/2024 |
| End date | |
| Name |
Start Date |
End date |
| Profs. Hugo Saner & David A Wood |
01/01/2003 |
31/12/2005 |
| Profs. Pantaleao Giannuzzi & David A Wood |
01/01/2006 |
31/12/2007 |
| Profs. Pantaleao Giannuzzi & Diederick Grobbee |
01/01/2008 |
31/12/2009 |
| Prof. Diederick Grobbee |
01/01/2010 |
31/12/2016 |
| Prof. Massimo Piepoli |
01/01/2017 |
31/03/2024 |
| Prof. Victor Aboyans |
01/04/2024 |
|
Our mission: To reduce the burden of cardiovascular disease.